Federal contract award
36C26024P0752
CANCER DRUG TRIAL PORTLAND VAHCS AND OHSU
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 260-NETWORK CONTRACT OFFICE 20 (36C260) |
| NAICS | 621511 — Medical Laboratories |
| PSC | AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $161.4K |
| Current contract value | $161.4K |
| Potential contract value / ceiling | $238.2K |
| Start date | Jul 1, 2024 |
| Current end date | Jun 30, 2027 |
| Potential end date | Jun 30, 2029 |
| Latest award activity | Oct 2, 2026 |
| Source loaded | Oct 17, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 2, 2026 | P00007 | $0 | CORRECT LINE-ITEM DESCRIPTIONS ON P00005, OPTION YEAR TWO |
| Sep 10, 2026 | P00006 | $-80.4K | EXERCISE OPTION YEAR ONE |
| Jun 24, 2026 | P00005 | $121.7K | EXERCISE OPTION YEAR ONE |
| Jun 17, 2026 | A14398 | $0 | IMPLEMENTING EO 14398 DEI DISCRIMINATION |
| Jun 23, 2025 | P00002 | $0 | ADJUST CLINS TO REFLECT ACTUAL COSTS. |
| Jun 23, 2025 | P00003 | $28.9K | EXERCISE OPTION YEAR ONE |
| Dec 10, 2024 | P00001 | $0 | CORRECT POP ON CLIN 1003 AND CHANGE BILLING FREQUENCY FROM ANNUALLY TO MONTHLY |
| Jun 28, 2024 | 0 | $91.1K | CANCER DRUG TRIAL PORTLAND VAHCS AND OHSU |
Estimated positioning window
Jun 30, 2028 – Dec 30, 2028
35/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 35/100. Available recorded signals: 30 points.
- Contract end 2029-06-30 (972 days from calculation)
- +15 points
- 1 historical awards in this buyer and category group
- +0 points
- 8 recorded award transactions
- +10 points
- Latest award action: 2026-10-02
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.